Cargando…
Modification of Apremilast from Pills to Aerosol a Future Concept
Background: Inhaled drugs have been available in the market for several years and for several diseases. Drugs for chronic obstructive pulmonary disease, cystic fibrosis, and diabetes have been used for several years. In the field of drug modification, these drugs range from tablets to aerosol. Metho...
Autores principales: | Zarogoulidis, Paul, Kosmidis, Christoforos, Kougkas, Nikolaos, Lallas, Aimilios, Petridis, Dimitris, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Freitag, Lutz, Sardeli, Chrisanthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582726/ https://www.ncbi.nlm.nih.gov/pubmed/34770103 http://dx.doi.org/10.3390/ijerph182111590 |
Ejemplares similares
-
Interventional bronchoscopy for HPV 16 and 66 with the use of spraying interferon-α (2b) plus bevacizumab and anti-reflux agent
por: Zarogoulidis, Paul, et al.
Publicado: (2021) -
Apremilast Survival and Reasons for Discontinuation in Psoriasis: Five-Year Experience From a Greek Tertiary Care Centre
por: Sotiriou, Elena, et al.
Publicado: (2022) -
Long Term Respiratory Follow-Up for COVID-19 Patients a Multicenter Study
por: BURSAC, DALIBORKA, et al.
Publicado: (2021) -
Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
por: Zarogoulidis, Paul, et al.
Publicado: (2022) -
Positron Emission-Computed Tomography, Cryobiopsy versus Bronchoalveolar Lavage and Computed Tomography Findings for Interstitial Lung Disease: A Long-Term Follow-Up
por: Zarogoulidis, Paul, et al.
Publicado: (2023)